150 related articles for article (PubMed ID: 9598572)
1. Development of fluoroquinolone resistance and mutations involving GyrA and ParC proteins among Neisseria gonorrhoeae isolates in Japan.
Tanaka M; Takahashi K; Saika T; Kobayashi I; Ueno T; Kumazawa J
J Urol; 1998 Jun; 159(6):2215-9. PubMed ID: 9598572
[TBL] [Abstract][Full Text] [Related]
2. Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro.
Tanaka M; Sakuma S; Takahashi K; Nagahuzi T; Saika T; Kobayashi I; Kumazawa J
Sex Transm Infect; 1998 Feb; 74(1):59-62. PubMed ID: 9634306
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan.
Shigemura K; Shirakawa T; Okada H; Hinata N; Acharya B; Kinoshita S; Kofuku T; Kawabata M; Kamidono S; Arakawa S; Gotoh A
Sex Transm Dis; 2004 Mar; 31(3):180-4. PubMed ID: 15076932
[TBL] [Abstract][Full Text] [Related]
4. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
[TBL] [Abstract][Full Text] [Related]
5. Reduced clinical efficacy of pazufloxacin against gonorrhea due to high prevalence of quinolone-resistant isolates with the GyrA mutation. The Pazufloxacin STD Group.
Tanaka M; Matsumoto T; Sakumoto M; Takahashi K; Saika T; Kabayashi I; Kumazawa J
Antimicrob Agents Chemother; 1998 Mar; 42(3):579-82. PubMed ID: 9517935
[TBL] [Abstract][Full Text] [Related]
6. Comparison of gyrA and parC mutations and resistance levels among fluoroquinolone-resistant isolates and laboratory-derived mutants of oral streptococci.
Kaneko A; Sasaki J; Shimadzu M; Kanayama A; Saika T; Kobayashi I
J Antimicrob Chemother; 2000 Jun; 45(6):771-5. PubMed ID: 10837428
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of a new fluoroquinolone, DU-6859a, against quinolone-resistant clinical isolates of Neisseria gonorrhoeae with genetic alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV.
Deguchi T; Yasuda M; Nakano M; Kanematsu E; Ozeki S; Ishihara S; Saito I; Kawada Y
J Antimicrob Chemother; 1997 Feb; 39(2):247-9. PubMed ID: 9069547
[TBL] [Abstract][Full Text] [Related]
8. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.
Shultz TR; Tapsall JW; White PA
Antimicrob Agents Chemother; 2001 Mar; 45(3):734-8. PubMed ID: 11181352
[TBL] [Abstract][Full Text] [Related]
9. Analysis of quinolone resistance mechanisms in a sparfloxacin-resistant clinical isolate of Neisseria gonorrhoeae.
Tanaka M; Nakayama H; Haraoka M; Nagafuji T; Saika T; Kobayashi I
Sex Transm Dis; 1998 Oct; 25(9):489-93. PubMed ID: 9800262
[TBL] [Abstract][Full Text] [Related]
10. gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya.
Kivata MW; Mbuchi M; Eyase FL; Bulimo WD; Kyanya CK; Oundo V; Muriithi SW; Andagalu B; Mbinda WM; Soge OO; McClelland RS; Sang W; Mancuso JD
BMC Microbiol; 2019 Apr; 19(1):76. PubMed ID: 30961546
[TBL] [Abstract][Full Text] [Related]
11. Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci.
Jorgensen JH; Weigel LM; Ferraro MJ; Swenson JM; Tenover FC
Antimicrob Agents Chemother; 1999 Feb; 43(2):329-34. PubMed ID: 9925527
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998.
Su X; Lind I
Antimicrob Agents Chemother; 2001 Jan; 45(1):117-23. PubMed ID: 11120953
[TBL] [Abstract][Full Text] [Related]
13. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
[TBL] [Abstract][Full Text] [Related]
14. Mutation patterns in gyrA and parC genes of ciprofloxacin resistant isolates of Neisseria gonorrhoeae from India.
Chaudhry U; Ray K; Bala M; Saluja D
Sex Transm Infect; 2002 Dec; 78(6):440-4. PubMed ID: 12473806
[TBL] [Abstract][Full Text] [Related]
15. Association between proline-requiring auxotype and fluoroquinolone resistance in Neisseria gonorrhoeae isolated in Japan.
Tsunoe H; Tanaka M; Mochida O; Nakayama H; Kanayama A; Saika T; Kobayashi I; Naito S
J Infect Chemother; 2001 Dec; 7(4):218-23. PubMed ID: 11810587
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998.
Tanaka M; Nakayama H; Haraoka M; Saika T
J Clin Microbiol; 2000 Feb; 38(2):521-5. PubMed ID: 10655338
[TBL] [Abstract][Full Text] [Related]
17. In-vitro antimicrobial activity of HSR-903, a new fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae with quinolone resistance-associated alterations in GyrA and ParC.
Deguchi T; Yasuda M; Ishihara S; Takahashi Y; Okezaki E; Nagata O; Saito I; Kawada Y
J Antimicrob Chemother; 1997 Sep; 40(3):437-9. PubMed ID: 9338500
[TBL] [Abstract][Full Text] [Related]
18. Susceptibilities of Neisseria gonorrhoeae isolates containing amino acid substitutions in GyrA, with or without substitutions in ParC, to newer fluoroquinolones and other antibiotics.
Tanaka M; Nakayama H; Haraoka M; Saika T; Kobayashi I; Naito S
Antimicrob Agents Chemother; 2000 Jan; 44(1):192-5. PubMed ID: 10602748
[TBL] [Abstract][Full Text] [Related]
19. Sparfloxacin resistance in clinical isolates of Streptococcus pneumoniae: involvement of multiple mutations in gyrA and parC genes.
Taba H; Kusano N
Antimicrob Agents Chemother; 1998 Sep; 42(9):2193-6. PubMed ID: 9736534
[TBL] [Abstract][Full Text] [Related]
20. Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong.
Ling JM; Chan EW; Lam AW; Cheng AF
Antimicrob Agents Chemother; 2003 Nov; 47(11):3567-73. PubMed ID: 14576119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
